SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-276826
Filing Date
2021-09-20
Accepted
2021-09-20 09:00:31
Documents
14
Period of Report
2021-09-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d234049d8k.htm   iXBRL 8-K 32513
2 EX-10.1 d234049dex101.htm EX-10.1 62719
3 EX-99.1 d234049dex991.htm EX-99.1 15044
  Complete submission text file 0001193125-21-276826.txt   264367

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aadi-20210914.xsd EX-101.SCH 2885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20210914_lab.xml EX-101.LAB 18887
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20210914_pre.xml EX-101.PRE 11855
7 EXTRACTED XBRL INSTANCE DOCUMENT d234049d8k_htm.xml XML 3486
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 211262195
SIC: 2834 Pharmaceutical Preparations